Annual report pursuant to Section 13 and 15(d)

NATURE OF OPERATIONS AND BASIS OF PRESENTATION (Details Narrative)

v3.22.1
NATURE OF OPERATIONS AND BASIS OF PRESENTATION (Details Narrative) - USD ($)
1 Months Ended 6 Months Ended 12 Months Ended
Jul. 14, 2021
Jul. 11, 2021
Feb. 02, 2021
Jan. 19, 2021
Jun. 12, 2020
Jun. 02, 2020
Jun. 02, 2020
Apr. 15, 2020
Feb. 24, 2020
Jan. 28, 2020
Jan. 28, 2020
Jan. 31, 2021
Jul. 31, 2021
Dec. 31, 2021
Dec. 31, 2020
Subsidiary, Sale of Stock [Line Items]                              
Number of shares issued   46,029,920                   14,900,000      
Number of warrants exercisable   23,014,960                          
Reverse stock split, description               the Company effected a 1-for-10 reverse stock split (the “Reverse Split”) of its issued and outstanding common stock.              
Proceeds from issuance of common stock   $ 36,259,050                          
Net income (loss)                           $ (37,525,898) $ (17,348,622)
Net cash used in operating activities                           66,184,477 25,063,170
Accumulated deficit                           $ (98,287,890) $ (60,761,992)
At The Market Offering Agreement [Member]                              
Subsidiary, Sale of Stock [Line Items]                              
Number of shares issued                       14,900,000 18,826,177    
Proceeds from issuance of common stock $ 40,000,000     $ 8,721,746                 $ 18,826,177    
Proceeds from public offering net of underwriting discounts and expenses                       $ 16,242,904      
Second At The Market Offering Agreement [Member]                              
Subsidiary, Sale of Stock [Line Items]                              
Proceeds from issuance of common stock     $ 100,000,000                        
Proceeds from public offering net of underwriting discounts and expenses                         $ 24,602,110    
Common Stock [Member] | At The Market Offering Agreement [Member]                              
Subsidiary, Sale of Stock [Line Items]                              
Number of shares issued 46,029,920                            
Proceeds from public offering net of underwriting discounts and expenses $ 36,259,050                            
Public Offering [Member]                              
Subsidiary, Sale of Stock [Line Items]                              
Number of shares issued         1,700,000       445,000            
Number of warrants exercisable                   2.4725 2.4725        
Proceeds from public offering net of underwriting discounts and expenses           $ 17,185,640         $ 8,549,470        
Public Offering [Member] | Common Stock [Member]                              
Subsidiary, Sale of Stock [Line Items]                              
Number of shares issued           19,000,000 19,000,000   445,000 4,500,000 4,500,000        
Proceeds from public offering net of underwriting discounts and expenses         $ 1,548,360       $ 839,270            
Public Offering [Member] | Warrant [Member]                              
Subsidiary, Sale of Stock [Line Items]                              
Number of shares issued           20,700,000 20,700,000     49,450,000 49.45